title: Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes.
abstract: CD4+ T cells of the Th1 type play a central role in acute rejection of solid tissue grafts, including orthotopic corneal allografts. Th1 cells, which mediate delayed hypersensitivity, are the polar opposites of CD4+ Th2 cells, and the latter cells cross-regulate Th1 cells through the unique pattern of cytokines they secrete. As such, Th2 cells may have a useful role to play in preventing rejection of corneal allografts. To test this possibility, the immune systems of adult mice were biased toward Th2 responses by immunization with keyhole limpet hemocyanin plus IFA. When immunized subsequently with either OVA or allogeneic corneal tissue, these mice acquired Ag-specific primed T cells of the Th2 type. More important, allogeneic corneas grafted into neovascularized eyes of Th2-biased mice experienced significantly enhanced survival. To demonstrate that enhanced survival was promoted by donor-specific Th2 cells, lymphoid cells from keyhole limpet hemocyanin-immune mice bearing healthy corneal allografts suppressed orthotopic corneal allograft rejection when adoptively transferred into naive, syngeneic recipients. We conclude that acceptance of corneal allografts in neovascularized mouse eyes can be significantly enhanced by biasing the recipient immune system toward Th2 responses.
authors.affiliation: Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114, USA.
authors.forename: J
authors.initials: J
authors.lastname: Yamada
authors.forename: M
authors.initials: M
authors.lastname: Yoshida
authors.forename: A W
authors.initials: AW
authors.lastname: Taylor
authors.forename: J W
authors.initials: JW
authors.lastname: Streilein
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D016039:Corneal Transplantation / Q000009:adverse effects / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D006082:Graft Enhancement, Immunologic; D006085:Graft Survival / Q000276:immunology*; D006433:Hemocyanins / Q000008:administration & dosage / Q000276:immunology; D016130:Immunophenotyping; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D012307:Risk Factors; D018418:Th2 Cells / Q000276:immunology*; D014181:Transplantation Immunology; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
chemical_list: D000941:Antigens; D018984:Epitopes, T-Lymphocyte; D010047:Ovalbumin; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin